TO STUDY THE EFFECT OF BARYTA CARBONICA AS A CHILDRENS REMEDY

A CLINICAL STUDY ON THE UTILIZATION OF BARYTA CARBONICA AS A PAEDIATRIC REMEDY - Nil

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/02/063030

Enrollment

Registered

2024-02-22

Start date

Unknown

Completion date

Unknown

Last updated

2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: R00-R99- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

Interventions

Intervention1: BARYTA CARBONICA: Single minimum dose orally For a period of 2 Weeks until next follow up Intervention2: BARYTA CARBONICA: Single minimum dose orally For a period of 2 Weeks until next

Eligibility

Inclusion criteria

Inclusion criteria: Age group: 1-18 years Children of Both sexes Cases indicated with Baryta carbonica – Based on constitution, symptomatology,intercurrent, past history, family history etc.,

Exclusion criteria

Exclusion criteria: Patients below 1 year and above 18 years of age. Cases which are prescribed with Baryta carbonica but interrupted with prescription of other deep acting remedy(ies).

Design outcomes

Primary

Measure	Time frame
Improvement after administration of Baryta carbonica in paediatric cases is taken as outcome assessment.Timepoint: Follow up after 2 weeks	—

Secondary

Measure	Time frame
NilTimepoint: Nil	—

Countries

India

Contacts

Public ContactShamini J S

Sarada Krishna Homoeopathic Medical College

hodpd@skhmc.org9489953018

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026